Results 181 to 190 of about 417,013 (351)

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

A pilot intervention to improve the management of urinary tract infections in outpatient settings. [PDF]

open access: yesAntimicrob Steward Healthc Epidemiol
Madaras-Kelly KJ   +9 more
europepmc   +1 more source

Descriptive Epidemiology of <i>Klebsiella</i> spp. Urinary Tract Infections in Central Africa. [PDF]

open access: yesBiomed Res Int
Mayombo Ngoussou E   +6 more
europepmc   +1 more source

Isolation, characterization, and molecular identification of Candida species from urinary tract infections

open access: diamond, 2019
Amin Gharanfoli   +5 more
openalex   +1 more source

Ketogenic diet for infantile epileptic spasms

open access: yesEpilepsia Open, EarlyView.
Abstract Approximately half of all cases of Infantile Epileptic Spasms Syndrome (IESS) do not respond to vigabatrin and hormonal therapies. There is no clear consensus as to the second‐line therapy for IESS. Ketogenic diet (KD) has emerged as an effective treatment for certain drug‐resistant epilepsies and in many cases of IESS.
Morris H. Scantlebury   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy